G(e)nome and trolls: Future risks of DNA sequencing

17 May 2017

What are the risks involved in DNA sequencing? As technological advances move forward at a rapid pace, it's hard for society to adapt at the same speed and make the bridge between science fiction and mainstream medical practice.

BLM healthcare partner Greg McEwen has authored an article for EPM Connecting Pharma about the current state of play in terms of development with genomic services when 2017 was intended to be a landmark year. Greg goes on to explain that all signs are pointing to DNA sequencing becoming the century's defining revolution.

To read Greg's full article on the EPM Connecting Pharma website, please click here.

<< Back

Disclaimer: This document does not present a complete or comprehensive statement of the law, nor does it constitute legal advice. It is intended only to highlight issues that may be of interest to customers of BLM. Specialist legal advice should always be sought in any particular case.

Related Sectors


Related contacts


Greg McEwen

Greg McEwen

Partner,
London


Who to contact


For more information about any of our news releases, please contact:

Natalie King
+44 20 7638 2811
+44 20 7920 0361
Email Natalie

Joanne Murray
+44 20 7638 2811
+44 20 7920 0361
Email Joanne

|